CVC  SR One

http://www.srone.com





     Office Locations:

985 Old Eagle School Road, Suite 511
Wayne, PA 19087
Phone: 610-567-1000
Fax: 610-567-1039

Get all office locations for this firm with a National Database subscription or Silicon Valley Database subscription.
 

Stages:

  • Early


 

Industries:

  • Life Sciences & Healthcare

  •  

    Description:

    SR One was GlaxoSmithKline's (GSK) independent corporate healthcare venture capital fund but recently spun out once closing its first independent fund. SR One is a leading trans-Atlantic biotech venture capital firm. SR One invests globally in emerging life science companies focused on drug discovery, development or delivery that have the potential to make products that can have a dramatic benefit to patients. SR One is interested in companies with products that are in preclinical development through clinical proof-of-concept. Overall, the firm looks for investments that can provide attractive financial returns and significant strategic value. The firm's current portfolio includes more than 30 private and public companies and since its founding in 1985, SR One has invested over $680MM in the biotech space.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Silicon Valley Database subscription.
    Amit Shah MD Senior Associate
    Chris Chai Venture Partner
    Daanish Jamal Associate
    Deborah Harland PhD Venture Partner
    Eliot Charles PhD Venture Partner

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      01/20/2023


      ADARx Pharmaceuticals


      CA


      $46,000,000


      Series B-1


      09/12/2022


      Nimbus Therapeutics


      MA


      $125,000,000


      


      06/14/2022


      Dren Bio


      CA


      $65,000,000


      Series B


     

    Portfolio companies include:

     

    Recent News: